L. CAROLINA GONZÁLEZ GÓMEZ; SANZ BLASCO S; NELSY BEATRIZ MEDINA; MARIA CLARA GRAVIELLE

REGULATION OF GABA A RECEPTORS BY PROLONGED EXPOSURE OF CORTICAL NEURONS TO BENZODIAZEPINES IS MEDIATED BY A CALCIUM SIGNALING PATHWAY

Reunión Anual de las Sociedades de Biociencias

Lugar: Mar del Plata; Año: 2022;

SANZ BLASCO S; ISAJA, LUCIANA; BORDONE M; STARK, AMY; GERSHANIK OS; FERRARIO JE

A combined pharmacological strategy to block NMDA receptor function and reduce L-DOPA induced dyskinesias

Society for Neuroscience Congress 2018

Lugar: San Diego; Año: 2018;

BORDONE M; DAMIANICH A; SANZ BLASCO S; BERNARDI MA; GERSHANIK OS; AVALE, M. ELENA; FERRARIO JE

A gene therapy approach to knock-down Fyn in the striatum reduces levodopa induced dyskinesia in the 6-hydroxydopamine mouse model of Parkinson?s disease.

Society for Neuroscience Congress 2018

Lugar: San Diego; Año: 2018;

LUCIANA ISAJA; SANZ BLASCO S; MELINA BORDONE; ANA DAMIANICH; ALEJANDRA BERNARDI; GIMENA GOMEZ; IRENE TARAVIN; ELENA AVALE; OSCAR GERSHANIK; JUAN FERRARIO

The kinase Fyn has an important role in NMDA receptor regulation in L-DOPA induced dyskinesia in a mouse model of Parkinson?s disease

XXXII Congreso SAN 2017

Lugar: Mar del Plata; Año: 2017;

M BORDONE; L ISAJA; SANZ BLASCO S; A DAMIANICH; E AVALE; O GERSHANIK; J FERRARIO

PNR2B mediates the role of FYN kinase in levodopa induced dyskinesia in a mouse model of Parkinson's disease

ISN-ESN Meeting

Lugar: Paris; Año: 2017;

GOMEZ G; BORDONE M; SANZ BLASCO S; BERNARDI MA; FERRARIO JE; TARAVINI I; MURER G; GERSHANIK OS

Characterization of striatal TH-immunoreactive cells in chronic and acute L-DOPA treatment in a mice model of Parkinson?s disease

20th International Congress of Parkinson's Disease and Movement Disorders

Lugar: Berlín; Año: 2016;

BORDONE M; BERNARDI MA; DAMIANICH A; SANZ BLASCO S; GOMEZ G; TARAVINI I; AVALE E; GERSHANIK OS; FERRARIO JE

Dissecting the molecular mechanisms of Fyn-mediated levodopa induced dyskinesias

20th International Congress of Parkinson's Disease and Movement Disorders

Lugar: Berlín; Año: 2016;

FERRARIO JE; SANZ BLASCO S; BORDONE M; DAMIANICH A; BERNARDI MA; GOMEZ G; TARAVINI I; AVALE E; GERSHANIK OS

The kinase Fyn mediates levodopa induced dyskinesias in Parkinson´s disease

20th International Congress of Parkinson's Disease and Movement Disorders

Lugar: Berlín; Año: 2016;

BERNARDI MA; SANZ BLASCO S; GOMEZ G; BORDONE M; DAMIANICH A; TARAVINI I; AVALE E; GERSHANIK OS; FERRARIO JE

THE FYN INHIBITOR SARACATINIB REDUCES LEVODOPA INDUCED DYSKINESIA IN PARKINSON?S DISEASE

XLVIII Reunión Anual de la Sociedad Argentina de Farmacología Experimental (SAFE)

Lugar: Mar del Plata; Año: 2016;

GOMEZ G; BALLESTERO P; SANZ BLASCO S; BERNARDI MA; GERSHANIK OS; TARAVINI I; FERRARIO JE

ADDRESSING THE MECHANISM OF PRIMING OF DOPAMINE RECEPTORS AND ITS EFFECT ON DRUGINDUCED DYSKINESIA

XLVIII Reunión Anual de la Sociedad Argentina de Farmacología Experimental (SAFE)

Lugar: Mar del Plata; Año: 2016;

BORDONE M; BERNARDI MA; DAMIANICH A; SANZ BLASCO S; GOMEZ G; TARAVINI I; AVALE E; GERSHANIK OS; FERRARIO JE

Unravelling the molecular role of Fyn in levodopa induced dyskinesia (LID)

2nd FALAN Congress

Lugar: Buenos Aires; Año: 2016;

GOMEZ G; BORDONE M; BERNARDI MA; SANZ BLASCO S; FERRARIO JE; TARAVINI I; MURER G; GERSHANIK OS

Characterization of striatal tyrosine hydroxylase-immunoreactive (TH-IR) cells in chronic and acute L-DOPA treatment in a mice model of Parkinson?s Disease

2nd FALAN Congress

Lugar: Buenos Aires; Año: 2016;

SANZ BLASCO S; AVALE E; CAMPANA S; SABORIDO M; GOMEZ G; TARAVINI I; GERSHANIK OS; FERRARIO JE

Exploring Fyn as a novel molecule in Levodopa induced dyskinesias

19th International Congress of Parkinson?s Disease and Movement Disorders

Lugar: San Diego; Año: 2015;

SANZ BLASCO S; DAMIANICH A; SABORIDO M; TARAVINI I; AVALE E; GERSHANIK OS; FERRARIO JE

Addressing a new target for L-DOPA induced dyskinesias

SfN 2015

Lugar: Chicago; Año: 2015;

AKHTAR MW; SANZ BLASCO S; DOLATABADI N; CHON K; PARKER J; AMBASUDHAN R; SOUSSOU R; MCKERCHER SR; NAKAMURA T; LIPTON SA

S-Nitrosylation of insulin degrading enzyme in Alzheimer's disease

SfN 2014

Lugar: Washington DC; Año: 2014;

MOLOKANOVA E; AKHTAR MW; SANZ BLASCO S; NAKAMURA T; OKAMOTO S; TU S; PIÑA-CRESPO JC; MCKERCHER SR; LIPTON SA

Differential effects of synaptic and extrasynaptic NMDA receptors on Aβ-induced nitric oxide Production in cerebrocortical neurons

58 Biophysical Society Meeting 2014

Lugar: San Francisco; Año: 2014;

SANZ BLASCO S; TALANTOVA M; ZHANG X; XIA P; AKHTAR MW; OKAMOTO S; DZIEWCZAPOLSKI G; NAKAMURA T; HIRES SA; STOUFFER DG; POWERS ET; KELLY JW; WOLOSKER H; WANG Y; PARSONS LH; HEINEMANN SF; PIÑA-CRESPO JC; LIPTON SA

Interaction between Ab and a7 nicotinic receptors releases glutamate from astrocytes and produces extrasynaptic NMDAR-mediated synaptic failure: prevention by NitroMemantine

Society for Neuroscience 2013

Lugar: San Diego; Año: 2013;

MOLOKANOVA E; SANZ BLASCO S; AKHTAR MW; MCKERCHER SR; OKAMOTO S; TU S; CAO G; PIÑA-CRESPO JC; LIPTON SA

Abeta effects on nitric oxide production in neurons: NOS activation via synaptic vs. extrasynaptic NMDA receptors

Society for Neuroscience 2012

Lugar: Nueva Orleans; Año: 2012;

DZIEWCZAPOLSKI G; SANZ BLASCO S; NAKAMURA T; GLOGOWSKI C; MASLIAH E; STOUFFER DG; PARSONS LH; HEINEMANN SF; LIPTON SA; PIÑA-CRESPO JC

Synaptic damage in Alzheimer's disease: mechanistic link between glutamatergic and cholinergic signaling pathways

5th ISN Special Conference

Lugar: Buenos Aires; Año: 2012;

SANZ BLASCO S; DZIEWCZAPOLSKI G; STOUFER DG; LEE B; WOLOSKER H; HEINEMANN SF; PARSONS LH; PINA CRESPO JC; LIPTON SA

Role of astrocytic glutamatergic signaling in abeta oligomers toxicity

Joint FEPS and Spanish Physiological Society Scientific Congress 2012

Lugar: Santiago de Compostela; Año: 2012;

SANZ BLASCO S; PIÑA-CRESPO JC; TALANTOVA M; LIPTON SA

Abeta-mediated glutamate release from astrocytes

10th International Conference on Alzheimer's & Parkinson's Diseases AD/PD.

Lugar: Barcelona; Año: 2011;

SANZ BLASCO S; PIÑA-CRESPO JC; TALANTOVA M; LIPTON SA

FRET Measurements of Aβ-Induced Glutamate Release from Astrocytes

136th Annual Meeting of the American Neurological Association

Lugar: San Diego; Año: 2011;

SANZ BLASCO S; PIÑA-CRESPO JC; TALANTOVA M; CAO G; LIPTON SA

Amyloid beta mediated glutamate release from astrocytes

Society for Neuroscience 2010

Lugar: San Diego; Año: 2010;